Sun Pharma recalls 200 vials of cancer drug: FDA

Tags: Companies
Sun Pharmaceutical Industries Ltd is recalling 200 vials of the chemotherapy drug gemcitabine in the United States due to a lack of assurance of sterility, the US Food and Drug Administration said on Thursday.

The drug being recalled was manufactured by Sun Pharma's unit Caraco Pharmaceutical Laboratories Ltd at its plant in Gujarat, the FDA said in a post on its website.

The voluntary recall was initiated in April and was classified by the FDA as Class II, meaning that use of or exposure to the recalled drug may cause temporary or medically reversible adverse health consequences.

This marks Sun Pharma's second drug recall this year. In January, the company started a voluntary recall of about 2,528 bottles of its generic version of diabetes drug Glumetza, after it received a customer complaint that one of the bottles contained tablets of an epilepsy drug.

EDITORIAL OF THE DAY

  • There is no reason why SEBs be burdened with unviable power assets

    It is indeed unfair that state power agencies be burdened with unviable power assets of Tatas, Essar, Reliance, Adani and other major power generators

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Sandeep Bamzai

Freedom Files : THE LAST SHEPHERD

The deep sense of foreboding was still to set in, ...

Rajgopal Nidamboor

Think outside the box

Creativity is the proviso of being resourceful. It connotes something ...

Kuruvilla Pandikattu

Tech is but a tool, digital era or not

Does our digital world make us make happier? We ...